Medical Marijuana Market Share | Forecasts Report, 2023-2032

Medical Marijuana Market - By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online) & Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Secondary

1.7.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.1.2&nbsp;&nbsp;&nbsp;Public sources

1.7.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Medical marijuana industry 3600&nbsp;synopsis, 2018-2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

2.1.3&nbsp;&nbsp;&nbsp; Route of administration trends

2.1.4&nbsp;&nbsp;&nbsp; Distribution channel trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Medical Marijuana Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 - 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Increasing application of marijuana for a myriad of medical conditions and symptoms

3.3.1.2&nbsp;&nbsp;&nbsp;Growing demand for medical marijuana legalization in several countries

3.3.1.3&nbsp;&nbsp;&nbsp;Rising number of R&amp;D and clinical trial activities

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Few side effects might hinder the market growth

3.3.2.2&nbsp;&nbsp;&nbsp;Difficulty in medical marijuana business banking

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By application

3.4.2&nbsp;&nbsp;&nbsp; By route of administration

3.4.3&nbsp;&nbsp;&nbsp; By distribution channel

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Value chain analysis

3.7&nbsp;&nbsp;&nbsp; Legal requirements for distribution of medical marijuana

3.8&nbsp;&nbsp;&nbsp; Regulatory landscape, by country

3.8.1&nbsp;&nbsp;&nbsp; U.S.

3.8.2&nbsp;&nbsp;&nbsp; Canada

3.8.3&nbsp;&nbsp;&nbsp; The Netherlands

3.8.4&nbsp;&nbsp;&nbsp; Israel

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Medical Marijuana Market, By Application

5.1&nbsp;&nbsp;&nbsp; Key application trends

5.2&nbsp;&nbsp;&nbsp; Pain management

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; Neuropathic pain

5.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.2.3&nbsp;&nbsp;&nbsp; Cancer pain

5.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.2.4&nbsp;&nbsp;&nbsp; Others

5.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Muscle spasms

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Nausea

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.5&nbsp;&nbsp;&nbsp; Anorexia

5.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.6&nbsp;&nbsp;&nbsp; Seizures

5.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

5.7&nbsp;&nbsp;&nbsp; Others

5.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Medical Marijuana Market, By Route of Administration

6.1&nbsp;&nbsp;&nbsp; Key route of administration trend

6.2&nbsp;&nbsp;&nbsp; Inhalation

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Oral

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Topical

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 &ndash; 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Medical Marijuana Market, By Distribution Channel

7.1&nbsp;&nbsp;&nbsp; Key distribution channel trend

7.2&nbsp;&nbsp;&nbsp; Dispensaries

7.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2018 &ndash; 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Online

7.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2018 &ndash; 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Medical Marijuana Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; Italy

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; UK

8.3.6&nbsp;&nbsp;&nbsp; The Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Denmark

8.3.8&nbsp;&nbsp;&nbsp; Ireland

8.4&nbsp;&nbsp;&nbsp; Latin America

8.4.1&nbsp;&nbsp;&nbsp; Brazil

8.4.2&nbsp;&nbsp;&nbsp; Mexico

8.4.3&nbsp;&nbsp;&nbsp; Argentina

8.4.4&nbsp;&nbsp;&nbsp; Columbia

8.4.5&nbsp;&nbsp;&nbsp; Chile

8.5&nbsp;&nbsp;&nbsp; Rest of world

8.5.1&nbsp;&nbsp;&nbsp; Australia

8.5.2&nbsp;&nbsp;&nbsp; Thailand

8.5.3&nbsp;&nbsp;&nbsp; Israel

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Canopy Growth Corporation

9.2&nbsp;&nbsp;&nbsp; Aurora Cannabis, Inc.

9.3&nbsp;&nbsp;&nbsp; Jazz Pharmaceuticals

9.4&nbsp;&nbsp;&nbsp; Medical Marijuana, Inc.

9.5&nbsp;&nbsp;&nbsp; Cannabis Sativa, Inc.

9.6&nbsp;&nbsp;&nbsp; Emerald Health Therapeutics Inc.

9.7&nbsp;&nbsp;&nbsp; The Cronos Group Inc.

9.8&nbsp;&nbsp;&nbsp; Tilray

9.9&nbsp;&nbsp;&nbsp; Lexaria Bioscience Corp

9.10&nbsp;&nbsp;&nbsp; Curaleaf

9.11&nbsp;&nbsp;&nbsp; Green Roads

9.12&nbsp;&nbsp;&nbsp; CHARLOTTE&rsquo;S WEB

9.13&nbsp;&nbsp;&nbsp; Gaia Herbs

9.14&nbsp;&nbsp;&nbsp; Folium Biosciences 
&nbsp;

Medical Marijuana Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters